ArticleBMC nephrology2025
Impact of fluorosis on mineral bone disorders in CKDu populations: a cross-sectional study.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease of unknown etiology (CKDu) and fluorosis are prevalent health issues in the dry zone of Sri Lanka. Mineral bone disorders (MBD) in CKDu-affected populations remain understudied, in Sri Lanka or elsewhere, creating a significant gap in knowledge. This cross-sectional study investigates MBD among CKDu patients living in fluorosis endemic regions.
methodsNinety-six non-dialysis CKDu patients were selected. Serum calcium, phosphate, vitamin D, parathyroid hormone, as well as urinary and serum fluoride levels were measured. Bone mineral density (BMD) of the spine and femur was assessed using Dual-Energy X-ray Absorptiometry (DEXA), while plain X-rays of the pelvis/lumbar spine and forearm were obtained. To determine the prevalence of MBD in early disease, patients were classified into early and late CKDu groups based on an estimated glomerular filtration rate (eGFR) cut-off of 45 ml/min/1.73 m².
resultsA high prevalence of MBD was identified, affecting 72% of subjects, with 64.5% presenting osteopenia or osteoporosis, predominantly within the axial skeleton. Of the cases assessed, 52% exhibited at least one biochemical abnormality. 25(OH) vitamin D levels were < 20 ng/ml in 16.7% and < 30 ng/ml in 62% of total cases. All patients demonstrated elevated serum fluoride levels, averaging 1.45 ± 1.2 mg/L, significantly higher than the reference range of 0.014–0.239 mg/L observed in healthy populations from non-fluorosis endemic regions. Radiological features in favor of skeletal fluorosis were noted, including interosseous membrane calcification (14.6%) and osteosclerosis (7.3%). Logistic regression analysis adjusted for age, sex, body mass index, and biochemical markers found that bone types did not predict differences in the prevalence of bone disease between early and late stage CKDu.
conclusionsIn Sri Lanka, mineral bone disorders of CKDu are different from typical CKD, as it resembles skeletal fluorosis with superadded effects of vitamin D insufficiency. Bone disorder risk is present even in the early stages of the disease. The study indicates that prolonged exposure to fluoride may contribute to early onset MBD in those with CKDu and highlights the need to assess fracture risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.